Related Experiment Video
Updated: Aug 12, 2026
07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Summary
Huntington's disease shows reduced glutamine synthetase activity in specific brain regions, not a general deficiency. This localized enzyme deficit may contribute to neuronal damage in affected areas.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Huntington's disease (HD) is a neurodegenerative disorder.
- Glutamine synthetase (GS) is a key enzyme in ammonia metabolism, primarily found in astrocytes.
Purpose of the Study:
- To investigate glutamine synthetase activity in various brain regions of patients with Huntington's disease.
- To determine if reduced GS activity contributes to the neurodegeneration observed in HD.
Main Methods:
- Post-mortem analysis of glutamine synthetase activity.
- Comparison of enzyme activity in seven distinct brain areas between control subjects and HD patients.
Main Results:
- Glutamine synthetase activity was significantly reduced in the frontal cortex, temporal cortex, putamen, and cerebellum of HD patients.
- No significant reduction in GS activity was observed in the hippocampus, thalamus, or olivary nucleus.
- The observed reductions were not indicative of a generalized GS deficiency in HD.
Conclusions:
- The localized decrease in glutamine synthetase activity in specific brain regions of HD patients may be linked to neuronal pathology.
- Given GS's role in ammonia assimilation and its astrocytic localization, reduced activity in areas with increased astrocyte-to-neuron ratios could signify a greater functional deficit.
- This enzyme's reduced function might exacerbate neuronal toxicity and contribute to the progression of Huntington's disease in affected areas.
